Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06309914 · ClinicalTrials.gov registry record · NA
The Effects of Mirtoselect®, Virtiva®, and Enovita® on Cognitive Performance and Mood States
A NA study, sponsored by Applied Science & Performance Institute.
- Completed
- Registry status
- NA
- Development phase
- 76
- Enrollment target
NCT06309914 is a NA study that has completed, run by Applied Science & Performance Institute. The registered enrollment target is 76 participants.
The verdict
NCT06309914, a NA study, has completed, sponsored by Applied Science & Performance Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 76 participants
- Enrollment target
Study Summary
This is a randomized, double-blind, placebo-controlled, 4-week intervention clinical study assessing the efficacy of Mirtoselect®, Virtiva® Plus, and Enovita® on cognitive performance and mood states, and the occurrence of adverse events in response to daily supplementation. The desired sample size for this study is 64 subjects. To account for potential dropouts, we aim to enroll up to 20% over the desired sample size. Therefore, this study will enroll up to 76 healthy men and women (25-55 years of age). Subjects will be randomly divided into four study groups: Placebo, Virtiva® ginkgo biloba extract, Mirtoselect® bilberry extract, or Enovita® grape seed extract. Blocked randomization will be deployed in which subjects are divided into blocks of 4 subjects and each subject within a block is randomly assigned to one of the four study groups.
Interventions
- DIETARY_SUPPLEMENT Placebo
- DIETARY_SUPPLEMENT Enovita Grape Seed Extract
- DIETARY_SUPPLEMENT Mirtoselect Bilberry Extract
- DIETARY_SUPPLEMENT Virtiva Plus Ginko Biloba Extract
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 76 participants |
| Start Date | 2024-02-21 |
| Est. Completion | 2024-07-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06309914
The ClinicalTrials.gov registry entry for NCT06309914 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 76 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Applied Science & Performance Institute, which has 20 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Placebo is the first listed.
NCT06309914 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06309914 about?
NCT06309914 is a clinical study titled "The Effects of Mirtoselect®, Virtiva®, and Enovita® on Cognitive Performance and Mood States". This is a randomized, double-blind, placebo-controlled, 4-week intervention clinical study assessing the efficacy of Mirtoselect®, Virtiva® Plus, and Enovita® on cognitive performance and mood states, and the occurrence of adverse events in response to daily supplementation. The desired sample size ...
What is the current status of trial NCT06309914?
This trial is currently completed. It is a NA study. The enrollment target is 76 participants. The study started on 2024-02-21. Estimated completion is 2024-07-08.
What interventions are being tested in trial NCT06309914?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Enovita Grape Seed Extract (DIETARY_SUPPLEMENT), Mirtoselect Bilberry Extract (DIETARY_SUPPLEMENT), Virtiva Plus Ginko Biloba Extract (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT06309914?
This trial is sponsored by Applied Science & Performance Institute, which has 20 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.